Protective effects of vitamin e and probucol against gentamicin-induced nephrotoxicity in rats.
Gentamicin (GM) is widely used as a bactericidal agent for the treatment of severe gram negative infections, however, its clinical use is partially limited due to its nephrotoxicity. Recent evidence suggests a role of reactive oxygen metabolites in GM nephrotoxicity. The present study was designed to investigate a possible potential protective role of vitamin E and/or probucol against GM nephrotoxicity. GM was administered to rats in a single dose of (150 mg kg(-1)i.p.), while vitamin E (250 mg kg(-1)i.m.) and/or probucol (60 mg kg(-1)i.m.) were given once daily for 3 consecutive days prior to GM administration. GM-induced nephrotoxicity was evidenced by marked elevations in serum urea and creatinine levels, urinary activity of N-acetyl-beta- d -glucosaminidase (NAG) and gamma-glutamyl-transferase (gamma-GT). Also, GM caused significant increases in kidney content of malondialdehyde (MDA), and significant decreases in kidney content of reduced non-protein sulphydryls (NPSH) and superoxide dismutase (SOD) activity. Vitamin E pretreatment significantly lowered the elevated serum urea and creatinine levels, and urinary activity of NAG and gamma-GT. In addition, vitamin E ameliorated the rise in renal content of MDA and enhanced the renal NPSH content as well as SOD activity. Similarly, probucol significantly inhibited the elevations in urea and creatinine levels and enhanced renal NPSH content and SOD activity. Simultaneous use of vitamin E and probucol was more effective in mitigating disturbances in the assessed parameters. The present work indicates that, due to their antioxidant activity, vitamin E and probucol have potential protective effects against GM nephrotoxicity.
Abdel-Naim
A B
AB
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.
Abdel-Wahab
M H
MH
Attia
F F
FF
D000118:Acetylglucosaminidase / Q000187:drug effects / Q000652:urine; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D003404:Creatinine / Q000097:blood; D004357:Drug Synergism; D005839:Gentamicins / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D011341:Probucol / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013482:Superoxide Dismutase / Q000187:drug effects / Q000378:metabolism; D014508:Urea / Q000097:blood; D014810:Vitamin E / Q000494:pharmacology*; D005723:gamma-Glutamyltransferase / Q000187:drug effects / Q000652:urine
D000924:Anticholesteremic Agents; D005839:Gentamicins; D013438:Sulfhydryl Compounds; D014810:Vitamin E; D008315:Malondialdehyde; D014508:Urea; D003404:Creatinine; D013482:Superoxide Dismutase; D005723:gamma-Glutamyltransferase; D000118:Acetylglucosaminidase; D011341:Probucol